Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common stock, $0.00001 par value per share
-
Shares outstanding
-
60.4M
-
Number of holders
-
209
-
Total 13F shares, excl. options
-
42.9M
-
Shares change
-
+3M
-
Total reported value, excl. options
-
$6.06B
-
Value change
-
+$546M
-
Put/Call ratio
-
1.04
-
Number of buys
-
106
-
Number of sells
-
-95
-
Price
-
$141.29
Significant Holders of Twist Bioscience Corp - Common stock, $0.00001 par value per share (TWST) as of Q4 2020
251 filings reported holding TWST - Twist Bioscience Corp - Common stock, $0.00001 par value per share as of Q4 2020.
Twist Bioscience Corp - Common stock, $0.00001 par value per share (TWST) has 209 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 42.9M shares
of 60.4M outstanding shares and own 71.02% of the company stock.
Largest 10 shareholders include ARK Investment Management LLC (5.88M shares), VANGUARD GROUP INC (3.52M shares), BlackRock Inc. (3.5M shares), Capital World Investors (2.95M shares), Invesco Ltd. (2.29M shares), Sumitomo Mitsui Trust Holdings, Inc. (1.85M shares), Nikko Asset Management Americas, Inc. (1.84M shares), JPMORGAN CHASE & CO (1.81M shares), Tao Capital Management LP (1.1M shares), and FMR LLC (1.1M shares).
This table shows the top 209 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.